Beijing Echo Biotech Co., Ltd.
PrivateLast Round
Series B
Nov 6, 2025
Total Funding Raised
$38.71M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Beijing Echo Biotech Co., Ltd. is a biotechnology company that provides exosome-related research services, GMP-grade exosome raw materials, and engineered exosome technology platforms for regenerative medicine and disease treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Echo Biotech Co., Ltd. Comparables
Compare Beijing Echo Biotech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Carrier Biomed (Suzhou) Co., Ltd. | 85% | |
| EXO Biologics | 80% | |
| CellBio Scientific | 77% |
Beijing Echo Biotech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 6, 2025 | ||||
| Series A Extension | Mar 3, 2023 | ||||
| Series A Extension | Jan 11, 2022 | ||||
| Series A | Jul 30, 2021 | ||||
| Pre Seed | Mar 25, 2019 |
Beijing Echo Biotech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongbo Juli | Series A Extension, Series B |
| Baidu Ventures | Series A Extension |
| Ennovation Ventures | Pre Seed |
| Volcanics Venture | Series A, Series A Extension |
| Beihang Investment Co., Ltd. | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 71% QoQ, from 7 to 12 employees.
- Jun 25, 2026
Grew 71% QoQ, from 7 to 12 employees.
Beijing Echo Biotech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beijing Echo Biotech Co., Ltd.'s valuation, stock price, and market status.
Is Beijing Echo Biotech Co., Ltd. a public or private company?
Beijing Echo Biotech Co., Ltd. is a private company.
What is the current stock price of Beijing Echo Biotech Co., Ltd.?
Beijing Echo Biotech Co., Ltd. is a private company with no public stock price. Caplight tracks Beijing Echo Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Beijing Echo Biotech Co., Ltd. worth (valuation)?
Valuation information for Beijing Echo Biotech Co., Ltd. is not publicly available.
Can I buy Beijing Echo Biotech Co., Ltd. stock?
Beijing Echo Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beijing Echo Biotech Co., Ltd.'s last funding round?
Beijing Echo Biotech Co., Ltd.'s most recent funding round was Series B on November 6, 2025.
Who are the main investors in Beijing Echo Biotech Co., Ltd.?
Key investors in Beijing Echo Biotech Co., Ltd. include Zhongbo Juli, Baidu Ventures.
Will Beijing Echo Biotech Co., Ltd. IPO soon?
No public IPO plans have been announced for Beijing Echo Biotech Co., Ltd..
How can I track Beijing Echo Biotech Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beijing Echo Biotech Co., Ltd.'s secondary market activity and sign up for updates.